Drug- and patient-specific neurological risk profiles of α1-adrenergic blockers: evidence from FAERS and external validation in JADER. [PDF]
Hai X, Huang L.
europepmc +1 more source
Ureteral stent symptoms: A systematic review and meta-analysis comparing the use of mirabegron and tamsulosin. [PDF]
Madarshahian D +4 more
europepmc +1 more source
Microbiota composition and intestinal barrier function modulated by tamsulosin and <i>Lactococcus lactis</i> in a cirrhosis rat model. [PDF]
Padilla-García SV +5 more
europepmc +1 more source
Mirabegron Versus Tamsulosin in Reducing Double-J Stent-Related Symptoms: A Prospective Comparative Study. [PDF]
Patil SR +3 more
europepmc +1 more source
Double versus standard dose of tamsulosin with solifenacin for management of ureteral stent related symptoms. [PDF]
Hefnawy A +4 more
europepmc +1 more source
Impact of Fixed-Dose Combination Versus Single-Component Therapy for Benign Prostatic Hyperplasia-Related Urinary Symptoms on Persistence, Adherence, and Satisfaction in a Real-Life Setting. [PDF]
Małkowski M +4 more
europepmc +1 more source
The influence of pre-stenting and drugs on the outcomes of ureteroscopy for kidney and ureteral stone disease: a systematic review and meta-analysis by the EAU Section of Endourology. [PDF]
Yuen SKK +11 more
europepmc +1 more source
Advancements in the use of enemas for treating urinary calculi. [PDF]
Ling M +13 more
europepmc +1 more source
Post-extracorporeal Membrane Oxygenation (ECMO) Bilateral Urolithiasis in an Adolescent With B-cell Acute Lymphoblastic Leukemia (ALL): A Case Report. [PDF]
Tobia González SG +2 more
europepmc +1 more source
Efficacy and Safety of Mirabegron and Tamsulosin Combination Therapy Compared to Tamsulosin Monotherapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Results of a Multicenter, Randomized, Double-Blind, Phase III Clinical Trial. [PDF]
Kam SC +18 more
europepmc +1 more source

